Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease

Neurobiology of Aging

Volumn 24, Issue 2, 2003, Pages 321-331

  Vehmas, Anne K ^a   Kawas, Claudia H ^b   Stewart, Walter F ^c   Troncoso, Juan C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

A peptide; Astrocyte; Dementia; Immunity; Microglia; Tau protein

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CADAVER; CELL ACTIVATION; CELL ACTIVITY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; MALE; MICROGLIA; MORPHOLOGY; NERVE INJURY; NEUROPIL; PATHOGENESIS; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ASTROCYTES; COGNITION DISORDERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROPIL; SENILE PLAQUES; TAU PROTEINS;

EID: 0037333633     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00090-8     Document Type: Article

References (52)

1. Afagh A., Cummings B.J., Cribbs D.H., Cotman C.W., Tenner A.J. Localization and cell association of C1q in Alzheimer's disease brain. Exp. Neurol. 138(1):1996;22-32.
2. Alzheimer A. Uber eine eigenartige erkrankung der hirnrinde. Allg. Z. Psychiatrie Psychisch-Gerichlich Med. 64:1907;146-148.
3. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7(1):1993;111-118.
4. Berg L., Miller J.P., Storandt M.et al. Mild senile dementia of the Alzheimer type. Part 2. Longitudinal assessment. Ann. Neurol. 23(5):1988;477-484.
5. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82(4):1991;239-259.
6. Chesler M. The regulation and modulation of pH in the nervous system. Prog. Neurobiol. 34(5):1990;401-427.
7. Crystal H., Dickson D., Fuld P.et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 38:1988;1682-1687.
8. del Rio Hortega P. Microglia in Cytology and Cellular Pathology of the Nervous System. In: Penfield W, editor. New York: Hoeber, 1932. p. 482-534.
9. Dickson D.W., Crystal H.A., Mattiace L.A.et al. Identification of normal and pathologic aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13(1):1992;179-189.
10. Fabry Z., Raine C.S., Hart M.N. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today. 15(5):1994;218-224.
11. Ferraro A. The origin and formation of senile plaques. Arch. Neurol. Psychiatry. 25:1931;1042-1062.
12. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12(3):1975;189-198.
13. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 307(5948):1984;273-276.
14. Funato H., Yoshimura M., Kusui K.et al. Quantitation of amyloid β-protein (Aβ) in the cortex during aging and in Alzheimer's disease. Am. J. Pathol. 152(6):1998;1633-1640.
15. Geula C., Wu C.K., Saroff D., Lorenzo A., Yuan M., Yankner B.A. Aging renders the brain vulnerable to amyloid-β protein neurotoxicity. Nat. Med. 4(7):1998;827-831.
16. Giulian D., Haverkamp L.J., Yu J.H.et al. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16(19):1996;6021-6037.
17. Gundersen H.J., Bendtsen T.F., Korbo L. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 96(5):1988;379-394.
18. Hertz L. Functional interactions between neurons and astrocytes. I. Turnover and metabolism of putative amino acid transmitters. Prog. Neurobiol. 13(3):1979;227-323.
19. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry. 140:1982;566-572.
20. Iwata N., Tsubuki S., Takaki Y. Identification of the major Aβ 1-42 degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6(2):2000;143-150.
21. Jendelova P., Sykova E. Role of glia in K+ and pH homeostasis in the neonatal rat spinal cord. Glia. 4(1):1991;56-63.
22. Katzman R., Terry R., DeTeresa R.et al. Clinical pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23(2):1988;138-144.
23. Kawas C., Karagiozis H., Resau L., Corrada M., Brookmeyer R. Reliability of the Blessed Telephone Information-Memory Concentration Test. J. Geriatr. Psychiatry Neurol. 8(4):1995;238-242.
24. Kawas C., Segal J., Stewart W., Corrada M., Thal L. Validation of an Informant Questionnaire for Determination of Dementia. Arch. Neurol. 51(9):1994;901-906.
25. Kidd M. Alzheimer's disease: an electron microscopical study. Brain. 87:1964;307-320.
26. Klegeris A., McGeer P.L. β-Amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Rev. 49:1997;229-235.
27. Ko L.W., Ko E.C., Nacharaju P.et al. An immunochemical study on tau glycation in paired helical filaments. Brain Res. 830(2):1999;301-313.
28. Kraig R.P., Pulsinelli W.A., Plum F. Hydrogen ion buffering during complete brain ischemia. Brain Res. 342(2):1985;281-290.
29. Lue L.F., Brachova L., Civin W.H., Rogers J. Inflammation, Abeta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J. Neuropathol. Exp. Neurol. 55(10):1996;1083-1088.
30. Luse S.A., Smith K.R. Jr. The ultrastructure of senile plaques. Am. J. Pathol. 44:1964;553-563.
31. McGeer P.L., McGeer E.G. The inflammatory system of brain: implications for therapy of Alzheimer and other neurodegenerative disorders. Brain Res. Rev. 21:1995;195-218.
32. McGeer P.L., Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 42(2):1992;447-449.
33. McKee A.C., Kosik K.S., Kowall N.W. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30(2):1991;156-165.
34. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Standlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34(7):1984;939-944.
35. Mirra S.S., Heyman A., McKeel D.et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
36. Ogura K., Ogawa M., Yoshida M. Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. Neuroreport. 5(10):1994;1224-1226.
37. Schousboe A. Transport and metabolism of glutamate and GABA in neurons and glial cells. Int. Rev. Neurobiol. 22:1981;1-45.
38. Selkoe D.J. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16(10):1993;403-409.
39. Sheng J.G., Mrak R.E., Griffin W.S. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. 94(1):1997;1-5.
40. Shock NW, Greulich RC, Costa Jr PT, et al. Normal Human Aging: The Baltimore Longitudinal Study of Aging. 1984.
41. Sisodia S.S., Price D.L. Role of the β-amyloid protein in Alzheimer's disease. FASEB J. 9(5):1995;366-370.
42. Soniat T.L.L. Histogenesis of senile plaques. Arch. Neurol. Psychiatry. 25:1931;1042-1062.
43. Troncoso C.J., Martin L.J., Dal Forno G., Kawas C.H. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol. Aging. 17(3):1996;365-371.
44. Uchihara T., Tsuchiya K., Nakamura A., Ikeda K. Appearance of tau-2 immunoreactivity in glial cells in human brain with cerebral infarction. Neurosci. Lett. 286:2000;99-102.
45. van Furth R. Current view on the mononuclear phagocyte system. Immunobiology. 161:1982;178-185.
46. Veerhuis R., Janssen I., Hack C.E., Eikelenboom P. Early complement components in Alzheimer's disease brains. Acta Neuropathol. 91:1996;53-60.
47. Walker DG, McGeer EG, McGeer PL. Involvement of inflammation and complement in Alzheimer's disease. Clinical neuroimmunology. In: Antel J, Birnbaum G, Hartung HP, editors. Oxford, UK: Blackwell Scientific Publishers, 1997. p. 172-88.
48. Walz W., Hertz L. Functional interactions between neurons and astrocytes. Part II. Potassium homeostasis at the cellular level. Prog. Neurobiol. 20:1983;133-183.
49. Walz W. Role of glial cells in the regulation of the brain ion microenvironment. Prog. Neurobiol. 33:1989;309-333.
50. Watanabe N., Takio K., Hasegawa M., Arai T., Titani K., Ihara Y. Tau 2: a probe for Ser conformation in the amino terminus of τ J. Neurochem. 58(3):1992;960-966.
51. Wisniewski HM, Terry RD. Reexamination of the pathogenesis of the senile plaque. Progress in neuropathology. In: Zimmerman HM, editor. New York: Grune and Stratton, 1973. p. 1-26.
52. Yamamoto T., Hirano A. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol. Appl. Neurobiol. 12(1):1986;3-9.